Effectiveness of pamidronate as treatment of symptomatic osteonecrosis occurring in children treated for acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 60, Issue 5, 2013, Pages 741-747

  Leblicq, Coralie ^a   Laverdière, Caroline ^a   Décarie, Jean Claude ^a   Delisle, Jean François ^a   Isler, Marc H ^a   Moghrabi, Albert ^a   Chabot, Gilles ^a   Alos, Nathalie ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Acute lymphoblastic leukemia; Bisphosphonates; Osteonecrosis

Indexed keywords

CALCIUM; DEXAMETHASONE; PAMIDRONIC ACID; PREDNISONE; VITAMIN D;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANKLE; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE NECROSIS; BONE PAIN; BONE RADIOGRAPHY; CANCER PATIENT; CANCER RADIOTHERAPY; CHILD; CHILDHOOD DISEASE; CHILDHOOD LEUKEMIA; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG EXPOSURE; FEMALE; HIP; HUMAN; INFUSION RELATED REACTION; JOINT MOBILITY; KNEE; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT DURATION;

ADOLESCENT; ARTHRALGIA; BONE DENSITY CONSERVATION AGENTS; CHILD; CHILD, PRESCHOOL; DIPHOSPHONATES; FEMALE; HUMANS; JOINTS; KNEE JOINT; MALE; MOTOR ACTIVITY; OSTEONECROSIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84874971522     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24313     Document Type: Article

References (32)

1. Mattano LA, Jr., Sather HN, Trigg ME, et al. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: A report from the Children's Cancer Group. J Clin Oncol 2000;18:3262-3272.
2. Bomelburg T, von Lengerke HJ, Ritter J. Aseptic osteonecroses in the treatment of childhood acute leukaemias. Eur J Pediatr 1989;149:20-23.
3. Pieters R, van der Schans-Dop AM, van Brenk AI, et al. Osteonecrosis following chemotherapy for leukemia. Eur J Haematol 1989;43:262-264.
4. Murphy RG, Greenberg ML. Osteonecrosis in pediatric patients with acute lymphoblastic leukemia. Cancer 1990;65:1717-1721.
5. Kawedia JD, Kaste SC, Pei D, et al. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood 2011;117:2340-2347.
6. te Winkel ML, Pieters R, Hop WC, et al. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. J Clin Oncol 2011;29:4143-4150.
7. Ojala AE, Paakko E, Lanning FP, et al. Osteonecrosis during the treatment of childhood acute lymphoblastic leukemia: A prospective MRI study. Med Pediatr Oncol 1999;32:11-17.
8. Niinimaki RA, Harila-Saari AH, Jartti AE, et al. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia. J Clin Oncol 2007;25:1498-1504.
9. Arico M, Boccalatte MF, Silvestri D, et al. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 2003;88:747-753.
10. Karimova EJ, Rai SN, Howard SC, et al. Femoral head osteonecrosis in pediatric and young adult patients with leukemia or lymphoma. J Clin Oncol 2007;25:1525-1531.
11. Sharma S, Yang S, Rochester R, et al. Prevalence of osteonecrosis and associated risk factors in children before allogeneic BMT. Bone Marrow Transplant 2011;46:813-819.
12. Wasilewski-Masker K, Kaste SC, Hudson MM, et al. Bone mineral density deficits in survivors of childhood cancer: Long-term follow-up guidelines and review of the literature. Pediatrics 2008;121:e705-e713.
13. Nguyen T, Zacharin MR. Pamidronate treatment of steroid associated osteonecrosis in young patients treated for acute lymphoblastic leukaemia-Two-year outcomes. J Pediatr Endocrinol Metab 2006;19:161-167.
14. Kotecha RS, Powers N, Lee SJ, et al. Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL). Pediatr Blood Cancer 2010;54:934-940.
15. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291-303.
16. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13-23.
17. Melmed S, Polonsky KS, Larsen PR, et al. Williams textbook of endocrinology, 12th edition. Philadelphia, PA, USA: Saunders; 2011. 1920 p.
18. Karimova EJ, Kaste SC. MR imaging of osteonecrosis of the knee in children with acute lymphocytic leukemia. Pediatr Radiol 2007;37:1140-1146.
19. Karimova EJ, Rai SN, Deng X, et al. MRI of knee osteonecrosis in children with leukemia and lymphoma: Part 1, observer agreement. AJR Am J Roentgenol 2006;186:470-476.
20. Karimova EJ, Rai SN, Ingle D, et al. MRI of knee osteonecrosis in children with leukemia and lymphoma: Part 2, clinical and imaging patterns. AJR Am J Roentgenol 2006;186:477-482.
21. Steinberg ME, Bands RE, Parry S, et al. Does lesion size affect the outcome in avascular necrosis? Clin Orthop Relat Res 1999;367:262-271.
22. Glorieux FH, Bishop NJ, Plotkin H, et al. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. New Engl J Med 1998;339:947-952.
23. Ribeiro RC, Fletcher BD, Kennedy W, et al. Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma. Leukemia 2001;15:891-897.
24. Johannesen J, Briody J, McQuade M, et al. Systemic effects of zoledronic acid in children with traumatic femoral head avascular necrosis and Legg-Calve-Perthes disease. Bone 2009;45:898-902.
25. Kraenzlin ME, Graf C, Meier C, et al. Possible beneficial effect of bisphosphonates in osteonecrosis of the knee. Knee Surg Sports Traumatol Arthrosc 2010;18:1638-1644.
26. Plotkin LI, Weinstein RS, Parfitt AM, et al. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 1999;104:1363-1374.
27. Bonabello A, Galmozzi MR, Bruzzese T, et al. Analgesic effect of bisphosphonates in mice. Pain 2001;91:269-275.
28. Munns CF, Rauch F, Ward L, et al. Maternal and fetal outcome after long-term pamidronate treatment before conception: A report of two cases. J Bone Miner Res 2004;19:1742-1745.
29. Hassen-Zrour S, Korbâa W, Béjia I, et al. Maternal and fetal outcome after long-term bisphosphonate exposure before conception. Osteoporos Int 2010;21:709-710.
30. Mastaglia SR, Watman NP, Oliveri B. Intravenous bisphosphonate treatment and pregnancy: Its effects on mother and infant bone health. Osteoporos Int 2010;21:1959-1962.
31. Chahine C, Cheung MS, Head TW, et al. Tooth extraction socket healing in pediatric patients treated with intravenous pamidronate. J Pediatr 2008;153:719-720.
32. Boonyapakorn T, Schirmer I, Reichart PA, et al. Bisphosphonate-induced osteonecrosis of the jaws: Prospective study of 80 patients with multiple myeloma and other malignancies. Oral Oncol 2008;44:857-869.